CYTX vs. ICU, LUCD, CODX, CTCX, DRIO, MDAI, LNSR, CTSO, MODD, and DXR
Should you be buying Cytori Therapeutics stock or one of its competitors? The main competitors of Cytori Therapeutics include SeaStar Medical (ICU), Lucid Diagnostics (LUCD), Co-Diagnostics (CODX), Carmell (CTCX), DarioHealth (DRIO), Spectral AI (MDAI), LENSAR (LNSR), Cytosorbents (CTSO), Modular Medical (MODD), and Daxor (DXR). These companies are all part of the "medical" sector.
Cytori Therapeutics (NASDAQ:CYTX) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.
SeaStar Medical has a net margin of 0.00% compared to Cytori Therapeutics' net margin of -242.60%. SeaStar Medical's return on equity of 0.00% beat Cytori Therapeutics' return on equity.
In the previous week, SeaStar Medical had 3 more articles in the media than Cytori Therapeutics. MarketBeat recorded 3 mentions for SeaStar Medical and 0 mentions for Cytori Therapeutics. SeaStar Medical's average media sentiment score of 0.33 beat Cytori Therapeutics' score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media.
Cytori Therapeutics has higher revenue and earnings than SeaStar Medical.
2.6% of Cytori Therapeutics shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 0.7% of Cytori Therapeutics shares are owned by company insiders. Comparatively, 4.5% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Cytori Therapeutics has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.18, suggesting that its share price is 218% less volatile than the S&P 500.
Cytori Therapeutics received 441 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 73.67% of users gave Cytori Therapeutics an outperform vote.
Summary
Cytori Therapeutics and SeaStar Medical tied by winning 6 of the 12 factors compared between the two stocks.
Get Cytori Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CYTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cytori Therapeutics Competitors List
Related Companies and Tools
